Skip to content
Clinical Trials – home
SpainBack to Spain

Clinical trials in Cordoba – page 42

564 clinical trials in Cordoba, Spain across 1 research site. Every trial is listed in the EU Clinical Trials Register and updated daily.

SpainOur site in SpainEnsayosClinicos.es(opens in a new tab)
Cordoba at a glance
564
clinical trials
  • Research sites1
Type of trial
Recruitment status
Quick filters

564 trials in Cordoba

Open in trial search
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Budigalimab
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Domvanalimab
  • Sponsor:Arcus Biosciences Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Bimatoprost
  • Sponsor:AbbVie Deutschland GmbH & Co. KG
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Pembrolizumab
  • Sponsor:Translational Research In Oncology
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Cemiplimab
  • Sponsor:Merck Healthcare KGaA
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Brimonidine Tartrate
  • Sponsor:Seagen Inc.
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Adagrasib
  • Sponsor:Mirati Therapeutics Inc.

Neoplasm malignant

Not recruiting
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Atezolizumab
  • Sponsor:NSABP Foundation Inc.
Registered drug
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Azacitidine
  • Sponsor:AbbVie Deutschland GmbH & Co. KG

Cardiac failure+1

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Igg Against Serum Albumin Fused With Relaxin 2, Chain B (2-29) And Relaxin 2 (Chain A)
  • Sponsor:Eli Lilly & Co.

Dyslipidaemia

Not recruiting
Investigational
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:1-[6-[[(1S,3S)-3-[[5-(Difluoromethoxy)Pyrimidin-2-Yl]Amino]Cyclopentyl]Amino]Pyridin-3-Yl]Pyridin-2-One
  • Sponsor:AstraZeneca AB
Countries:SpainSpain
  • Participants:18–64 years · 65+ years
  • Substances:Patritumab Deruxtecan
  • Sponsor:Solti Group

Other cities in Spain

The busiest research cities in the country

All 218 cities in Spain

Clinical research in Cordoba

What the registry says about research in the country

01 Oncology Research

Advanced clinical trials focusing on novel treatments for various cancer types, including metastatic colorectal cancer, non-small cell lung cancer, and prostate cancer. Studies evaluate innovative therapeutic approaches and combination treatments.

  • Colorectal Cancer Therapeutics
  • Prostate Cancer Treatments
  • Lung Cancer Interventions

Investigations include targeted therapies and immunotherapy combinations for improved patient outcomes.

02 Immunology Studies

Comprehensive research into autoimmune conditions, including systemic sclerosis, atopic dermatitis, and psoriatic arthritis. Clinical trials evaluate new biological treatments and their effectiveness.

  • Autoimmune Disease Therapies
  • Dermatological Conditions
  • Inflammatory Disorders

Focus on developing targeted treatments for chronic inflammatory conditions.

03 Infectious Disease Prevention

Vaccine development studies targeting cytomegalovirus (CMV) and respiratory syncytial virus (RSV). Research aims to prevent infections in vulnerable populations.

  • Viral Infection Prevention
  • Vaccine Development
  • Immune Response Studies

Emphasis on vaccine efficacy and safety in different age groups.

Clinical Trials Concierge

Prefer not to search? Our Concierge searches the trials for you.

Tell us about your condition – we search every trial in Europe and connect you with the right site.